Sustanon 250 mg/ml Pharmacore (Testoterone blend)
Sustanon 250 mg/ml by Pharmacore Laboratories LTD is an injectable testosterone formulation containing four testosterone esters. Its declared concentration is 250 mg/ml, presented in a 10 ml vial according to the product label.
The formulation combines different testosterone esters with distinct pharmacokinetic characteristics. Understanding its composition helps customers identify the product and its principal pharmaceutical features.
Sustanon 250 mg/ml Ingredients
The product label specifies four active ingredients with a combined concentration of 250 mg per millilitre.
1. Testosterone Propionate – 30 mg/ml
Testosterone propionate is a shorter-acting testosterone ester. It contributes to the formulation’s overall pharmacokinetic profile.
2. Testosterone Phenylpropionate – 60 mg/ml
Testosterone phenylpropionate is another active ester in the formulation. Its characteristics complement those of the other ingredients.
3. Testosterone Isocaproate – 60 mg/ml
Testosterone isocaproate contributes to the combination of release characteristics associated with the formulation.
4. Testosterone Decanoate – 100 mg/ml
Testosterone decanoate is a longer-acting testosterone ester. It contributes to the overall pharmacokinetic profile of the preparation.
Together, these four ingredients account for the declared concentration of 250 mg/ml. The complete excipient list should be confirmed through the product’s official documentation.
Key Features and Potential Advantages
Sustanon 250 mg/ml combines four testosterone esters in one injectable preparation. Its principal distinguishing feature is this combination of active ingredients.
Key product characteristics include:
- Four testosterone esters in one formulation.
- A declared concentration of 250 mg/ml.
- A 10 ml vial presentation, as indicated on the label.
- Different pharmacokinetic characteristics associated with the individual esters.
Testosterone has established medical uses for appropriately diagnosed testosterone deficiency. Under medical supervision, replacement therapy may improve certain symptoms associated with low testosterone.
Individual outcomes depend on clinical circumstances and treatment suitability. Results are not guaranteed, and the product should not be presented as a general-purpose performance supplement.
Possible Side Effects and Considerations
Testosterone treatment may cause acne, fluid retention, changes in libido, and mood changes. Other possible effects include increased haematocrit, changes in blood pressure, and alterations in cholesterol levels.
Testosterone can also reduce sperm production and affect fertility. Appropriate medical assessment and monitoring help evaluate individual suitability and treatment outcomes.
Customers should review the complete ingredient list, particularly when allergies are relevant. Product-specific information about excipients, storage, and manufacturing should be confirmed through official documentation.
Frequently Asked Questions | Sustanon 250 mg/ml Pharmacore
1. What is Sustanon 250 mg/ml?
Sustanon 250 mg/ml is an injectable testosterone formulation containing four testosterone esters, with a declared combined concentration of 250 mg/ml.
2. Which ingredients does Sustanon 250 contain?
The label lists Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, and Testosterone Decanoate.
3. What are the quantities of each ingredient?
The declared quantities per millilitre are 30 mg, 60 mg, 60 mg, and 100 mg, respectively.
4. What distinguishes Sustanon 250 mg/ml?
Its main distinguishing feature is the combination of four testosterone esters within one formulation.
5. What are the possible side effects?
Possible effects include acne, fluid retention, changes in libido, mood changes, increased haematocrit, and reduced sperm production.
6. What should customers check before they buy Sustanon 250?
Customers should review the product label, ingredient list, packaging, batch information, supporting documentation, and applicable legal requirements.
Sustanon 250 mg/ml: Understanding the Formulation by Pharmacore
Sustanon 250 mg/ml by Pharmacore Laboratories LTD catalog features four testosterone esters with a declared combined concentration of 250 mg/ml. Its composition and presentation define its principal product characteristics.
Clear product information helps customers understand the formulation while supporting accurate, professional communication. The label and official documentation remain the appropriate references for confirming product-specific details.
